Results
1 -
10 of
13
(Click
here to explore results)
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs . Lianhong Xu, Manoj C. Desai
, 2013
, Pages 451-481
Successful Strategies for the Discovery of Antiviral Drugs, Contents
, 2013
, Pages P009-P016
Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection . Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 14 Clinical Benefits of Singleātablet Regimens . Danielle P. Porter, Bill Guyer
, 2013
, Pages 482-508
Amino Acids, Peptides and Proteins: Volume 41, Peptide-derived mid-sized anti-HIV agents . Nami Ohashi, Hirokazu Tamamura
, 2017
, Volume 41
, Pages 1-29
Green Chemistry Strategies for Drug Discovery, Chapter 13 The Business Case for Green Chemistry in Drug Discovery . Joseph M. D. Fortunak, Martins O. Emeje, Harriet Kammendi, Ermias L. Tilahun, Xiang S. Wang
, 2015
, Pages 280-313
Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 10 Development Programs for Oral Fixed Dose Combination Products . Patrick J. Crowley, Sharon M. Maglennon, Luigi G. Martini, David Templeton
, 2022
, Pages 259-286
Green Chemistry Strategies for Drug Discovery, Subject Index
, 2015
, Pages 314-322
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, Subject Index
, 2022
, Volume 2
, Pages 625-650